Biocatalytic Composition Patent for Lung Cancer Treatment
Summary
Biocatalytic Composition Patent for Lung Cancer Treatment
Archived snapshot
Apr 11, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
FUNCTIONALIZED BIOCATALYTICAL COMPOSITIONS
Application US20260097103A1 Kind: A1 Apr 09, 2026
Inventors
Emilie LAPRÉVOTTE, Miquel CATALA, Yves Victor René DUDAL, Patrick SHAHGALDIAN
Abstract
The present invention relates to a composition comprising a solid carrier, an enzyme or a fragment thereof immobilized on the surface of the solid carrier, a protective layer to protect the enzyme or the fragment thereof by embedding the enzyme or the fragment thereof, and a functional constituent immobilized on the surface of the protective layer. The present invention also relates to a method for the prevention, delay of progression or treatment of lung cancer in a subject using said composition and methods of producing said composition.
CPC Classifications
A61K 38/50 A61K 9/5031 A61K 9/5052 C12N 9/82 C12N 11/14 C12Y 305/01001
Filing Date
2023-09-19
Application No.
19113222
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.